V010-6771 Screening compound: N-[4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide

V010-6771 Screening compound: N-[4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide
V010-6771 Screening compound: N-[4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-6771
N-[4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-6771

Molecular Formula

C27H30F3N3O4 (C27 H30 F3 N3 O4)

Compound Name

N-[4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide

IUPAC name

(2S)-N-[(1r4r)-4-(4-methoxybenzamido)cyclohexyl]-1-[4-(trifluoromethyl)benzoyl]pyrrolidine-2-carboxamide

SMILES

COc(cc1)ccc1C(N[C@H](CC1)CC[C@@H]1NC(C(CCC1)N1C(c1ccc(C(F)(F)F)cc1)=O)=O)=O

InChI

InChI=1S/C27H30F3N3O4/c1-37-22-14-6-17(7-15-22)24(34)31-20-10-12-21(13-11-20)32-25(35)23-3-2-16-33(23)26(36)18-4-8-19(9-5-18)27(28,29)30/h4-9,14-15,20-21,23H,2-3,10-13,16H2,1H3,(H,31,34)(H,32,35)/t20?,21?,23-/m0/s1

InChI Key

CDWNANJZGMZPEE-BBHUYCHWSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

517.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.696

Distribution Coefficient, logD

3.696

Water Solubility, LogSw

-3.92

Polar Surface Area

72.576

Acid Dissociation Constant (pKa)

14.47

Base Dissociation Constant (pKb)

1.44

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.40

V010-6771 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V010-6771 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-6771?
Check Price and Availability of V010-6771, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-6771 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-6771
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-6771
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-6771 available by request